Huffstutter: Keep Physician-Patient Relationship Healthy in 2015

Huffstutter: Keep Physician-Patient Relationship Healthy in 2015

February 28th, 2015 by By Dr. Joseph Huffstutter in Opinion Columns

A new class of biologic medications is giving a new lease on life for many patients. Biologics are used to treat many conditions -- most prevalently in the areas of oncology, rheumatology, neurology and dermatology. In 2015, a variation of these medications called biosimilars will become available. To realize the full potential of these medications, I strongly support proposed legislation that provides for communication from the pharmacist to the patient and the doctor whenever a pharmacist dispenses a substitution.

Biosimilars and those deemed interchangeable by the FDA hold great promise and will be useful in treating a variety of medical conditions. However, because biologics and biosimilars are unique drugs with different molecular structures, it's important that both the physician and the patient know exactly which drug the patient is taking.

Current legislation before the Tennessee General Assembly (HB 572 and SB 984) would require pharmacists to communicate to physicians which biological product they dispensed. Ultimately, this legislation is about protecting the physician-patient relationship, because physicians need accurate information to monitor patients' progress with disease progression and medication side effects to direct treatment.

The biosimilars that pharmacists may provide as a substitute will be new to the market this year. They are poised to give patients more options and, many hope, to lower prescription drug costs. It's important to realize that these biosimilars are not generics. These drugs, which stem from living cells or tissue, represent powerful medical technology. Physicians frequently prescribe them to patients who suffer from rheumatoid arthritis, multiple sclerosis and some types of cancer.

I think of one of my own patients, a woman who worked in a local school cafeteria and suffered from explosive onset rheumatoid arthritis. Her husband had to carry her in his arms to my office because her arthritis was so bad that she couldn't walk.

Now, after eight years on a biological medicine, this woman leads a different life. Retired from her work in the cafeteria, she and her husband devote themselves to mission work in Third-World countries.

But what if the medication hadn't been a good fit for her? I would have offered an alternative, and then another until we found something that worked. That's the nature of the physician-patient relationship. The physician knows their patients, monitors their progress and response to medications, and collaborates with them to maintain the best health possible.

This legislation supports that aspect of clinical care by making certain that physicians have all the pertinent details -- communication from the pharmacist will ensure a complete and accurate medical record. I can't monitor my patient and determine which medicines work if I'm unsure which medicine my patient is taking.

And while knowing about prescription drug substitutions always helps, with biological medicines and biosimilars it becomes imperative. Whether it's seeing a new side effect emerge or an old symptom disappear, I need to know which medication caused which response. That's why an up-to-date communication protocol between the pharmacist and the physician is so important.

All patients deserve first-rate care from an informed, attentive health care provider. And that's what I want to provide. This legislation will ensure that this happens.

Dr. Joseph Huffstutter is a Chattanooga rheumatologist and serves on the National Physicians Biologics Working Group with the Alliance for Patient Access.

Getting Started/Comments Policy

Getting started

  1. 1. If you frequently comment on news websites then you may already have a Disqus account. If so, click the "Login" button at the top right of the comment widget and choose whether you'd rather log in with Facebook, Twitter, Google, or a Disqus account.
  2. 2. If you've forgotten your password, Disqus will email you a link that will allow you to create a new one. Easy!
  3. 3. If you're not a member yet, Disqus will go ahead and register you. It's seamless and takes about 10 seconds.
  4. 4. To register, either go through the login process or just click in the box that says "join the discussion," type your comment, and either choose a social media platform to log you in or create a Disqus account with your email address.
  5. 5. If you use Twitter, Facebook or Google to log in, you will need to stay logged into that platform in order to comment. If you create a Disqus account instead, you'll need to remember your Disqus password. Either way, you can change your display name if you'd rather not show off your real name.
  6. 6. Don't be a huge jerk or do anything illegal, and you'll be fine.

Chattanooga Times Free Press Comments Policy

The Chattanooga Times Free Press web sites include interactive areas in which users can express opinions and share ideas and information. We cannot and do not monitor all of the material submitted to the website. Additionally, we do not control, and are not responsible for, content submitted by users. By using the web sites, you may be exposed to content that you may find offensive, indecent, inaccurate, misleading, or otherwise objectionable. You agree that you must evaluate, and bear all risks associated with, the use of the Times Free Press web sites and any content on the Times Free Press web sites, including, but not limited to, whether you should rely on such content. Notwithstanding the foregoing, you acknowledge that we shall have the right (but not the obligation) to review any content that you have submitted to the Times Free Press, and to reject, delete, disable, or remove any content that we determine, in our sole discretion, (a) does not comply with the terms and conditions of this agreement; (b) might violate any law, infringe upon the rights of third parties, or subject us to liability for any reason; or (c) might adversely affect our public image, reputation or goodwill. Moreover, we reserve the right to reject, delete, disable, or remove any content at any time, for the reasons set forth above, for any other reason, or for no reason. If you believe that any content on any of the Times Free Press websites infringes upon any copyrights that you own, please contact us pursuant to the procedures outlined in the Digital Millennium Copyright Act (Title 17 U.S.C. § 512) at the following address:

Copyright Agent
The Chattanooga Times Free Press
400 East 11th Street
Chattanooga, TN 37403
Phone: 423-757-6315
Email: webeditor@timesfreepress.com


Loading...